Profiling of 149 Salivary Duct Carcinomas, Carcinoma Ex Pleomorphic Adenomas, and Adenocarcinomas, Not Otherwise Specified Reveals Actionable Genomic Alterations.

Wang, Kai; Russell, Jeffery S; McDermott, Jessica D; Elvin, Julia A; Khaira, Depinder; Johnson, Adrienne; Jennings, Timothy A; Ali, Siraj M; Murray, Molly; Marshall, Carrie; Oldham, Dwight S; Washburn, Donna; Wong, Stuart J; Chmielecki, Juliann; Yelensky, Roman; Lipson, Doron; Miller, Vincent A; Stephens, Philip J; Serracino, Hilary S; Ross, Jeffrey S; Bowles, Daniel W

Wang, Kai; Russell, Jeffery S; McDermott, Jessica D; Elvin, Julia A; Khaira, Depinder; Johnson, Adrienne; Jennings, Timothy A; Ali, Siraj M; Murray, Molly; Marshall, Carrie; Oldham, Dwight S; Washburn, Donna; Wong, Stuart J; Chmielecki, Juliann; Yelensky, Roman; Lipson, Doron; Miller, Vincent A; Stephens, Philip J; Serracino, Hilary S; Ross, Jeffrey S; Bowles, Daniel W.

Afiliação

Wang K; Foundation Medicine, Inc, Cambridge, Massachusetts.
Russell JS; Zhejiang Cancer Hospital, Hangzhou, China.
McDermott JD; Moffitt Cancer Center, University of South Florida, Tampa, Florida.
Elvin JA; Division of Medical Oncology, University of Colorado School of Medicine, Aurora, Colorado.
Khaira D; Foundation Medicine, Inc, Cambridge, Massachusetts.
Johnson A; Foundation Medicine, Inc, Cambridge, Massachusetts.
Jennings TA; Foundation Medicine, Inc, Cambridge, Massachusetts.
Ali SM; Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, New York.
Murray M; Foundation Medicine, Inc, Cambridge, Massachusetts.
Marshall C; Foundation Medicine, Inc, Cambridge, Massachusetts.
Oldham DS; Department of Pathology, University of Colorado School of Medicine, Aurora, Colorado.
Washburn D; Centra Hematology Oncology Clinic, Alan B. Pearson Regional Cancer Center, Lynchburg, Virginia.
Wong SJ; Centra Hematology Oncology Clinic, Alan B. Pearson Regional Cancer Center, Lynchburg, Virginia.
Chmielecki J; Division of Hematology Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
Yelensky R; Foundation Medicine, Inc, Cambridge, Massachusetts.
Lipson D; Foundation Medicine, Inc, Cambridge, Massachusetts.
Miller VA; Foundation Medicine, Inc, Cambridge, Massachusetts.
Stephens PJ; Foundation Medicine, Inc, Cambridge, Massachusetts.
Serracino HS; Foundation Medicine, Inc, Cambridge, Massachusetts.
Ross JS; Department of Pathology, University of Colorado School of Medicine, Aurora, Colorado.
Bowles DW; Foundation Medicine, Inc, Cambridge, Massachusetts. daniel.bowles@ucdenver.edu jross@foundationmedicine.com.

Clin Cancer Res ; 22(24): 6061-6068, 2016 Dec 15.

Article em En | MEDLINE | ID: mdl-27334835

Assuntos

Adenocarcinoma/genética; Adenoma Pleomorfo/genética; Carcinoma Ductal/genética; Rearranjo Gênico/genética; Mutação/genética; Neoplasias das Glândulas Salivares/genética; Feminino; Genômica/métodos; Humanos; Masculino; Fosfatidilinositol 3-Quinases/genética; Proteínas Proto-Oncogênicas c-akt/genética; Receptor ErbB-2/genética; Ductos Salivares/metabolismo; Serina-Treonina Quinases TOR/genética

Buscar no Google

Imprimir

XML

PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias das Glândulas Salivares / Rearranjo Gênico / Adenocarcinoma / Adenoma Pleomorfo / Carcinoma Ductal / Mutação Limite: Female / Humans / Male Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article

Buscar no Google

Imprimir

XML

PubMed Links